Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trials

BACKGROUND: The prognosis of patients with gastrointestinal stromal tumor (GIST) after the failure of standard therapies is poor with supportive care alone. Guidelines recommend clinical trials, and patients with good performance status following standard therapies are often eligible for phase I cli...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: Nagatani, Yoshiaki, Shitara, Kohei, Bando, Hideaki, Kuboki, Yasutoshi, Okamoto, Wataru, Kojima, Takashi, Yoshino, Takayuki, Nishida, Toshirou, Ohtsu, Atushi, Doi, Toshihiko
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5109764/
https://ncbi.nlm.nih.gov/pubmed/27842521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2939-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items